Inactive Instrument

Company Tongli Pharmaceuticals (USA) Inc OTC Bulletin Board

Equities

US89025Q1067

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Tongli Pharmaceuticals (USA) Inc

Business Summary

Tongli Pharmaceuticals (USA), Inc. through its wholly owned subsidiary, Harbin Tianmu Pharmaceuticals Co., Ltd. (HTP), is a pharmaceutical company engaged in the production, manufacturing and distribution of both prescription and non-prescription over-the-counter (OTC) medicines in China. The company has the following types of productions: tablets, capsules, granules, oral liquid, etc, more than 10 types. The annual capacity of the company includes 300 million tablets, 250 million capsules, 10 million bags of granules and 36 million pipes of oral liquid. The Company's products are Calcium Gluconate Oral Solution, Blood Circulation Peomotion Oral Solution, Antihyperlipidemics, Gynecologic Leucorrhea Stopping Tablet, Panax and Radix Polygoni Capsule, among others.

Managers

Managers TitleAgeSince
Chief Executive Officer 73 98-12-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 73 98-12-31
Director/Board Member 74 10-01-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,728,111 11,056,444 ( 75.07 %) 0 75.07 %

Company contact information

Tongli Pharmaceuticals (USA), Inc.

42-60 Main Street Apartment 6F

11355, Flushing

+

address Tongli Pharmaceuticals (USA) Inc
  1. Stock Market
  2. Equities
  3. TGLP Stock
  4. Stock
  5. Company Tongli Pharmaceuticals (USA) Inc